https://www.medscape.com/viewarticle/979861
0
0
8/28/22 at 5:45pm
Organization
Medscape
Author
Patrice Wendling
39 words
0
Comments
A striking and unexpected reduction in death with the use of predominantly warfarin was just one of the many surprises delivered by the INVICTUS trial at ESC 2022.
You are the first to view
Create an account
or login to join the discussion